Deborah Persaud, MD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

A clinician and researcher specializing in the study and treatment of  HIV-1 infection in children, Deborah Persaud directors the pediatric infectious diseases fellowship program at Hopkins Children’s. A 1985 graduate of the New York University School of Medicine, she trained in pediatrics at Babies Hospital/ Columbia Presbyterian Medical Center in New York, where she was chief resident. She was an infectious disease fellow, an Aaron Diamond Post Doctoral Research Fellow and a faculty member at New York University. She joined Johns Hopkins’ faculty in 1997 following a visiting lectureship at the Moi University, Eldoret, Kenya.

  • Member, Immune Activation Focus Group of Inflammation TSG
  • External Investigator Appointed, HIV Reservoirs and Viral Eradication Transformative Science Group
  • Chair, IMPAACT HIV CURE Scientific Committee

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

Read More

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

A5300B/I2003B/PHOENIX, Protecting Households On Exposure to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

Read More